The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients

• Main Authors: Sahar H. Elhini (Author), Engy A. Wahsh (Author), Ahmed A. Elberry (Author), Nadia F. El Ameen (Author), Ahmed Abdelfadil Saedii (Author), Shereen Mahmoud Refaie (Author), Asmaa A. Elsayed (Author), Hoda M. Rabea (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is related to metabolic syndrome via insulin resistance, where preventing disease progression is crucial in the management process. The study included 240 NAFLD patients with type 2 diabetes who were randomly allocated into empagliflozin 25 mg (EMPA group),...